logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > PRASUGREL HYDROCHLORIDE CAS 389574-19-0

PRASUGREL HYDROCHLORIDE CAS 389574-19-0

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 389574-19-0

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,T/T,D/P,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

CAS 389574-19-0 PRASUGREL HYDROCHLORIDE

,

PRASUGREL HYDROCHLORIDE

CAS NO::
389574-19-0
Appearance::
White To Off-white Solid
Molecular Formula::
C20H21ClFNO3S
Molecular Weight::
409.90200
EINECS NO::
627-126-4
MDL NO::
MFCD11867705
CAS NO::
389574-19-0
Appearance::
White To Off-white Solid
Molecular Formula::
C20H21ClFNO3S
Molecular Weight::
409.90200
EINECS NO::
627-126-4
MDL NO::
MFCD11867705
PRASUGREL HYDROCHLORIDE CAS 389574-19-0

Product Description:

Product Name: PRASUGREL HYDROCHLORIDE CAS NO: 389574-19-0


Synonyms:

Prasugrel HCl;

[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl]acetate hydrochloride;

Prasugren hydrochloride;

 

Chemical & Physical Properties:

Appearance: White to off-white solid

Assay :≥99.00%

Boiling Point: 493.5℃ at 760 mmHg


Safety Information:

HS Code: 2934990002


Prasugrel (trade name Effient in the US and India, and Efient in the EU) is a pharmaceutical drug that acts as a platelet inhibitor and is used to prevent thrombosis (blood clotting). It was developed by Daiichi Sankyo Co. and produced by Ube and currently marketed in the United States in cooperation with Eli Lilly and Company.

Prasugrel was approved for use in Europe in February 2009, and in the US in July 2009, for the reduction of thrombotic cardiovascular events (including stent thrombosis) in people with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI).


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.